Ophthalmic Devices are those devices which are used for vision correction or in ophthalmic diagnostic interventions. Ophthalmic Laser Devices create a uniform and coherent light which can be continuous or pulsed in treating a wide spectrum of diseases involving both the anterior and posterior segments of the eye for correcting refractive disorders. GlobalData uses proprietary data and analytics to provide a comprehensive report on the ophthalmic lasers devices market, including market shares of different players within Switzerland. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the ophthalmic lasers market in Switzerland was Johnson & Johnson Vision Care followed by Alcon, Bausch & Lomb, Meridian, Carl Zeiss Meditec, Lensar, SCHWIND eye-tech-solutions, Aurolab, Iridex and Nidek.
Excimer Lasers, Femtosecond Lasers and YAG Lasers are covered under Ophthalmic Lasers. Excimer Lasers are used for photorefractive surgery to correct vision (myopia, hyperopia, astigmatism) and glaucoma treatment. Yttrium-Aluminium-Garnet (YAG) Laser is a laser whose active medium is a crystal of yttrium, aluminium, and garnet doped with neodymium ions that is used as a lasing medium for solid-state lasers. YAG Lasers are used for photocoagulation and photo ablation. A Femtosecond Laser is a laser which emits optical pulses.
The value of the ophthalmic lasers devices market within Switzerland was expected to be over $4m in 2023.
For the latest complete market share analysis of ophthalmic lasers device market in Switzerland, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
